Correlation Between Gilead Sciences and Evaxion Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Evaxion Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Evaxion Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Evaxion Biotech AS, you can compare the effects of market volatilities on Gilead Sciences and Evaxion Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Evaxion Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Evaxion Biotech.

Diversification Opportunities for Gilead Sciences and Evaxion Biotech

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Gilead and Evaxion is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Evaxion Biotech AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaxion Biotech AS and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Evaxion Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaxion Biotech AS has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Evaxion Biotech go up and down completely randomly.

Pair Corralation between Gilead Sciences and Evaxion Biotech

Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.27 times more return on investment than Evaxion Biotech. However, Gilead Sciences is 3.66 times less risky than Evaxion Biotech. It trades about 0.2 of its potential returns per unit of risk. Evaxion Biotech AS is currently generating about -0.07 per unit of risk. If you would invest  6,280  in Gilead Sciences on September 2, 2024 and sell it today you would earn a total of  2,978  from holding Gilead Sciences or generate 47.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Gilead Sciences  vs.  Evaxion Biotech AS

 Performance 
       Timeline  
Gilead Sciences 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating essential indicators, Gilead Sciences exhibited solid returns over the last few months and may actually be approaching a breakup point.
Evaxion Biotech AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evaxion Biotech AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Gilead Sciences and Evaxion Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gilead Sciences and Evaxion Biotech

The main advantage of trading using opposite Gilead Sciences and Evaxion Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Evaxion Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaxion Biotech will offset losses from the drop in Evaxion Biotech's long position.
The idea behind Gilead Sciences and Evaxion Biotech AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm